Skip to main content

Table 2 Resected colorectal adenocarcinoma patients analysed by immunohistochemistry for APRIL protein expression on tissue microarray

From: APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling

Variable

Frequency/median(range)

Age

71 years (22-92)

Gender

 

Male

121

Female

113

Histological Grade

 

Poor

27

Moderate

199

Well

8

Tumour site

 

Proximal colon

79

Distal colon

86

Rectum

69

Stage

 

I

46

II

86

III (adjuvant chemotherapy)1

102 (63)

   N2

48

  1. 1In this series 63/102 (62%) Stage III patients received adjuvant chemotherapy with 5FU
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us